Clinical Trial Update: PK of SOF/LED in HCV - Infected Adolescents With Haematological Disorders [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the pharmacokinetics of sofosbuvir/ledipasvir in adolescents with hepatitis C infection and beta-thalassemia major.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta Thalassemia Major
• Hepatitis C

Drugs mentioned

• Sofosbuvir/Ledipasvir (sofosbuvir/ledipasvir)

Snippet

Sponsor: Ain Shams University | Conditions: HCV Infection, Beta Thalassemia Major | Phase 3 | Status: UNKNOWN